Lei MM - Search Results

1

Denosumab versus intravenous bisphosphonate use for hypercalcemia in multiple myeloma.

Lei MM, Tavares E, Buzgo E, Lou U, Raje N, Yee AJ. Lei MM, et al. Leuk Lymphoma. 2022 Dec;63(13):3249-3252. doi: 10.1080/10428194.2022.2115840. Epub 2022 Aug 29. Leuk Lymphoma. 2022. PMID: 36036363 No abstract available.

2

Safety and efficacy of a urine alkalinization protocol developed for high-dose methotrexate patients during intravenous bicarbonate shortage.

Roy AM, Lei M, Lou U. Roy AM, et al. J Oncol Pharm Pract. 2019 Dec;25(8):1860-1866. doi: 10.1177/1078155218821406. Epub 2019 Jan 12. J Oncol Pharm Pract. 2019. PMID: 30636529

3

Current management and emerging treatment strategies for multiple myeloma.

Lei M, Kim EB, Branagan A, Lou U, Zemel M, Raje N. Lei M, et al. Rinsho Ketsueki. 2019;60(9):1243-1256. doi: 10.11406/rinketsu.60.1243. Rinsho Ketsueki. 2019. PMID: 31597850 Review.

4

Current Treatment Strategies for Multiple Myeloma.

Branagan A, Lei M, Lou U, Raje N. Branagan A, et al. JCO Oncol Pract. 2020 Jan;16(1):5-14. doi: 10.1200/JOP.19.00244. JCO Oncol Pract. 2020. PMID: 32039665 Review.

5

Evaluation of the impact of timing of pegfilgrastim administration on incidence of febrile neutropenia in elderly patients with B-cell non-Hodgkin lymphomas receiving R-CHOP-21.

Lei MM, Watson AN, Abramson JS. Lei MM, et al. Leuk Lymphoma. 2020 Dec;61(12):2998-3001. doi: 10.1080/10428194.2020.1795157. Epub 2020 Jul 18. Leuk Lymphoma. 2020. PMID: 32686543 No abstract available.

6

Evaluating the incidence of chemotherapy-induced nausea and vomiting in patients with B-cell lymphoma receiving dose-adjusted EPOCH and rituximab.

Uchida E, Lei MM, Roeland E, Lou U. Uchida E, et al. Among authors: lei mm. J Oncol Pharm Pract. 2022 Jan;28(1):119-126. doi: 10.1177/1078155220985919. Epub 2021 Jan 12. J Oncol Pharm Pract. 2022. PMID: 33435826

7

The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil-Associated Coronary Vasospasm.

Zafar A, Drobni ZD, Mosarla R, Alvi RM, Lei M, Lou UY, Raghu VK, Murphy SP, Jones-O'Connor M, Hartmann S, Gilman HK, Weekes CD, Clark JR, Clark J, Blaszkowsky L, Tavares E, Neilan TG. Zafar A, et al. JACC CardioOncol. 2021 Mar;3(1):101-109. doi: 10.1016/j.jaccao.2020.12.005. Epub 2021 Mar 16. JACC CardioOncol. 2021. PMID: 33817666 Free PMC article.

8

The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm.

Zafar A, Drobni ZD, Lei M, Gongora CA, Quinaglia T, Lou UY, Mosarla R, Murphy SP, Jones-O'Connor M, Mahmood A, Hartmann S, Gilman HK, Weekes CD, Nipp R, Clark JR, Clark JW, Blaszkowsky LS, Tavares E, Neilan TG. Zafar A, et al. PLoS One. 2022 Apr 7;17(4):e0265767. doi: 10.1371/journal.pone.0265767. eCollection 2022. PLoS One. 2022. PMID: 35390017 Free PMC article.

9

Letermovir and tacrolimus interaction effects in hematopoietic cell transplantation recipients receiving moderate cytochrome P450 3A4 inhibitors for antifungal prophylaxis.

Malespini J, Lei M, Tavares E, Hammond SP, Chen YB, Luk SO, DeFilipp Z. Malespini J, et al. J Oncol Pharm Pract. 2023 Oct;29(7):1574-1579. doi: 10.1177/10781552221139772. Epub 2022 Nov 17. J Oncol Pharm Pract. 2023. PMID: 36398324 Review.

10

Combined analysis of the impact of second-generation BTK inhibitors on patient outcomes.

Redd RA, Ford J, Lei M, Abramson JS, Soumerai JD. Redd RA, et al. Leuk Lymphoma. 2023 Dec;64(14):2296-2305. doi: 10.1080/10428194.2023.2254876. Epub 2023 Dec 25. Leuk Lymphoma. 2023. PMID: 37798861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page